Výsledky vyhledávání - "MESH: Hyperkalemia"

Efficacy and safety of the pharmacotherapy used in the management of hyperkalemia: a systematic review

Autor: Varallo, Fabiana R., Trombotto, Victória, Lucchetta, Rosa C., Mastroianni, Patricia de C.

Publikováno v: Pharmacy Practice, Vol 17, Iss 1, p 1361 (2019)
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Pharmacy Practice (Granada), Volume: 17, Issue: 1, Article number: 1361, Published: 11 NOV 2019
Pharmacy Practice
Pharmacy Practice (Granada) v.17 n.1 2019
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname

Background: Although the management of hyperkalemia follows expert guidelines, treatment approaches are based on traditionally accepted practice standards. New drugs have been assessed such as sodium zirconium cyclosilicate and patiromer; however, th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a83408c9e13b0695ad67b18a34d0cc4f
https://www.pharmacypractice.org/journal/index.php/pp/article/view/1361

Zobrazit plný text záznamu

New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval

Autor: Mikhail Kosiborod, Maria Angeles Alonso Garcia, Norman Stockbridge, Henrik S. Rasmussen, Javed Butler, Aliza Thompson, Bertram Pitt, Murray Epstein, Lance Berman, Alexandre Mebazaa, Faiez Zannad, George L. Bakris, Janet Wittes, Patrick Rossignol, Luis M. Ruilope, Wendy Gattis Stough

Publikováno v: International Journal of Cardiology
International Journal of Cardiology, Elsevier, 2016, 216, pp.46-51. ⟨10.1016/j.ijcard.2016.04.127⟩

International audience; Hyperkalemia is a common clinical problem, especially in patients with chronic kidney disease, diabetes mellitus, or heart failure. Treatment with renin angiotensin aldosterone system inhibitors exacerbates the risk of hyperka

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ac4a020faacccca71325f2fd5518d6f
https://pubmed.ncbi.nlm.nih.gov/27140336

Zobrazit plný text záznamu

The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure

Autor: Patrick Rossignol, Bertram Pitt

Publikováno v: Expert Opinion on Drug Safety
Expert Opinion on Drug Safety, Informa Healthcare, 2016, 15 (5), pp.659-65. ⟨10.1517/14740338.2016.1163335⟩

Mineralocorticoid receptor antagonists (MRAs) have been accorded a class 1 indication for patients with chronic heart failure and a reduced left ventricular ejection fraction (HFREF) in both European and American guidelines. Uptake, however, has been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fab84ea7e0b0e546fe0cd76059b97530
https://pubmed.ncbi.nlm.nih.gov/26958701

Zobrazit plný text záznamu

Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial

Autor: Timothy Collier, Nicolas Girerd, Stuart J. Pocock, John J.V. McMurray, John Vincent, Henry Krum, Bertram Pitt, Karl Swedberg, Faiez Zannad, Dirk J. van Veldhuisen

Publikováno v: European Heart Journal, 36(34), 2310-2317. Oxford University Press
European Heart Journal
European Heart Journal, Oxford University Press (OUP): Policy B, 2015, 36 (34), pp.2310-2317. ⟨10.1093/eurheartj/ehv273⟩

International audience; AIMS:Cardiovascular hospitalization (CVH) in patients with heart failure (HF) is associated with a high post-discharge rate of early re-admission and CV death. Eplerenone might be effective in reducing the incidence of these a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b15e19599d89c546667b48c64577482
https://research.rug.nl/en/publications/d8b54891-0f7e-404b-905e-d1ffa7e0ba77

Zobrazit plný text záznamu

Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial

Autor: Bhupinder Singh, Peter van der Meer, Prakash Deedwania, Faiez Zannad, Gerasimos Filippatos, Piotr Ponikowski, Ileana L. Piña, Stefan D. Anker, Philip T. Lavin, Mikhail Kosiborod, Alex Yang, Peter A. McCullough, Henrik S. Rasmussen

Publikováno v: European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2015, 17 (10), pp.1050-1056. ⟨10.1002/ejhf.300⟩
European Journal of Heart Failure, 17(10), 1050-1056. Wiley

International audience; AIMS:Hyperkalaemia in heart failure patients limits use of cardioprotective renin-angiotensin-aldosterone system inhibitors (RAASi). Sodium zirconium cyclosilicate (ZS-9) is a selective potassium ion trap, whose mechanism of a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5ea97d6d3551d2af9fd5371eda3b102
https://pubmed.ncbi.nlm.nih.gov/26443125

Zobrazit plný text záznamu

Plný text ve formátu HTML

Changes in Serum Potassium Levels During Hospitalization in Patients With Worsening Heart Failure and Reduced Ejection Fraction (from the EVEREST Trial)

Autor: Michele Senni, Haris Subacius, Umberto Campia, Muthiah Vaduganathan, Aldo P. Maggioni, Javed Butler, Savina Nodari, Faiez Zannad, Sadiya S. Khan, Patrick Rossignol, Marvin A. Konstam, Mihai Gheorghiade, Karl Swedberg, Ovidiu Chioncel

Publikováno v: American Journal of Cardiology
American Journal of Cardiology, Elsevier, 2015, 115 (6), pp.790-796. ⟨10.1016/j.amjcard.2014.12.045⟩

International audience; Both hyperkalemia and hypokalemia may be related to heart failure (HF) therapy and are associated with adverse outcomes. Abnormalities in serum potassium levels in hospitalized patients with HF and reduced ejection fraction (E

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffcbcfd0970274ded2d8aedf67b74183
https://hal.univ-lorraine.fr/hal-01742963

Zobrazit plný text záznamu

Timing of onset of CKD-related metabolic complications

Autor: Moranne, Olivier, Froissart, Marc, Rossert, Jérôme, Gauci, Cédric, Boffa, Jean-Jacques, Haymann, Jean-Philippe, M'Rad, Mona Ben, Jacquot, Christian, Houillier, Pascal, Stengel, Bénédicte, Fouqueray, Bruno

Publikováno v: Journal of the American Society of Nephrology
Journal of the American Society of Nephrology, American Society of Nephrology, 2009, 20 (1), pp.164-71. ⟨10.1681/ASN.2008020159⟩
Journal of the American Society of Nephrology, American Society of Nephrology, 2009, 20 (1), pp.164-71. 〈10.1681/ASN.2008020159〉
Journal of the American Society of Nephrology, 2009, 20 (1), pp.164-71. ⟨10.1681/ASN.2008020159⟩

International audience; Chronic kidney disease (CKD) guidelines recommend evaluating patients with GFR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9f63a88dcaeee26c0cd6b2e5c857e435
https://www.hal.inserm.fr/inserm-00555033/file/Complications_JASN_Txt_HAL.pdf

Zobrazit plný text záznamu

Incident hyperkalemia may be an independent therapeutic target in low ejection fraction heart failure patients: Insights from the HEAAL study

Autor: Marvin A. Konstam, Douglas Gregory, Michael S. Kiernan, Daniela Dobre, Joseph M. Massaro, Faiez Zannad, Patrick Rossignol

Publikováno v: International Journal of Cardiology
International Journal of Cardiology, Elsevier, 2014, 173 (3), pp.380-387. ⟨10.1016/j.ijcard.2014.02.034⟩

International audience; BACKGROUND:Angiotensin receptor antagonists (ARBs) improve outcomes in patients with heart failure (HF) with reduced left ventricular ejection fraction, but may induce hyperkalemia (HK) and/or a worsening of renal function (WR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d76d29c1093cfd811982f750f90a78f5
https://hal.univ-lorraine.fr/hal-01739554

Zobrazit plný text záznamu

Timing of onset of CKD-related metabolic complications.: Onset of CKD-Related Metabolic Complications

Publikováno v: Journal of the American Society of Nephrology
Journal of the American Society of Nephrology, 2009, 20 (1), pp.164-71. ⟨10.1681/ASN.2008020159⟩

International audience; Chronic kidney disease (CKD) guidelines recommend evaluating patients with GFR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1398::9f63a88dcaeee26c0cd6b2e5c857e435
https://www.hal.inserm.fr/inserm-00555033

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání